AXT-201

N/A

Report date: 2024/11/08 15:30:24
NME

Base Information

Drug NameAXT-201
Drug Alias NameAXT-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsTEK receptor tyrosine kinase stimulants
TargetsVascular endothelial growth factor receptor 2TEK receptor tyrosine kinase
Therapy Area/IndicationsSolid tumoursBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsclepiX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAsclepiX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A